Dumont & Blake Investment Advisors LLC Raises Stock Holdings in Cigna Group $CI

Dumont & Blake Investment Advisors LLC boosted its holdings in Cigna Group (NYSE:CI) by 21.0% in the second quarter, Holdings Channel.com reports. The institutional investor owned 6,068 shares of the health services provider’s stock after acquiring an additional 1,054 shares during the period. Dumont & Blake Investment Advisors LLC’s holdings in Cigna Group were worth $2,006,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in CI. Brighton Jones LLC grew its stake in shares of Cigna Group by 9.3% during the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after purchasing an additional 318 shares during the period. GAMMA Investing LLC grew its stake in shares of Cigna Group by 79.0% during the 1st quarter. GAMMA Investing LLC now owns 5,394 shares of the health services provider’s stock valued at $1,775,000 after purchasing an additional 2,381 shares during the period. CWA Asset Management Group LLC grew its stake in shares of Cigna Group by 17.8% during the 1st quarter. CWA Asset Management Group LLC now owns 932 shares of the health services provider’s stock valued at $306,000 after purchasing an additional 141 shares during the period. Boston Trust Walden Corp bought a new stake in shares of Cigna Group during the 1st quarter valued at about $233,000. Finally, Blue Trust Inc. grew its stake in shares of Cigna Group by 16.4% during the 1st quarter. Blue Trust Inc. now owns 2,245 shares of the health services provider’s stock valued at $739,000 after purchasing an additional 316 shares during the period. 86.99% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

CI has been the subject of a number of recent research reports. Wolfe Research cut their price target on Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday. Wall Street Zen downgraded Cigna Group from a “buy” rating to a “hold” rating in a research note on Friday, October 3rd. Cantor Fitzgerald reiterated an “overweight” rating and set a $365.00 price objective on shares of Cigna Group in a research note on Tuesday, August 26th. Wells Fargo & Company boosted their price objective on Cigna Group from $340.00 to $354.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 7th. Finally, TD Cowen upgraded Cigna Group to a “strong-buy” rating in a research note on Monday, June 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Cigna Group has an average rating of “Moderate Buy” and a consensus target price of $369.89.

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the company’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the transaction, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This represents a 52.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the transaction, the insider owned 51,182 shares of the company’s stock, valued at $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Trading Up 3.0%

CI stock opened at $299.81 on Friday. Cigna Group has a 1-year low of $256.89 and a 1-year high of $353.55. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The company has a market capitalization of $80.03 billion, a price-to-earnings ratio of 16.37, a PEG ratio of 0.88 and a beta of 0.45. The business has a 50 day simple moving average of $297.27 and a two-hundred day simple moving average of $308.13.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. During the same period in the prior year, the company posted $6.72 EPS. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Research analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were paid a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 2.0%. The ex-dividend date was Thursday, September 4th. Cigna Group’s dividend payout ratio is presently 32.97%.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.